Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Conmed (CNMD) Operating Expenses (2016 - 2026)

Conmed filings provide 17 years of Operating Expenses readings, the most recent being $158.0 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 2.33% to $158.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $644.1 million, a 15.52% increase, with the full-year FY2025 number at $647.9 million, up 21.62% from a year prior.
  • Operating Expenses hit $158.0 million in Q1 2026 for Conmed, down from $181.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $181.7 million in Q4 2025 to a low of $113.3 million in Q3 2024.
  • Median Operating Expenses over the past 5 years was $137.8 million (2023), compared with a mean of $140.9 million.
  • Biggest five-year swings in Operating Expenses: decreased 17.76% in 2024 and later skyrocketed 36.15% in 2025.
  • Conmed's Operating Expenses stood at $133.0 million in 2022, then fell by 0.73% to $132.0 million in 2023, then increased by 10.5% to $145.8 million in 2024, then increased by 24.56% to $181.7 million in 2025, then decreased by 13.01% to $158.0 million in 2026.
  • The last three reported values for Operating Expenses were $158.0 million (Q1 2026), $181.7 million (Q4 2025), and $154.2 million (Q3 2025) per Business Quant data.